Indian Drugmaker Taps Private Credit for Japanese Acquisition

Gujarat Themis Biosyn Ltd. secured private credit funding to acquire MicroBiopharm Japan Co., highlighting the growing use of such debt for overseas expansion in Asia.

1 publisher · 1 article · first seen 29 Sept 2026 · updated 3d ago

This story has stopped developing; this page is its permanent record. More from that day

The story so far

1 publisher has covered this in 1 article since 29 Sept 2026. Bloomberg Markets published first, on 29 September at 01:31 UTC.

No prediction market is linked to this story at the moment. We match each story to Polymarket and Kalshi markets by what they ask, and show one only when it is close enough to be useful; if a market on this topic opens, it will appear here. Meanwhile, browse every market we track or see how stories and markets are matched.

Embed this story

Paste this into any web page to show the live odds, with a link back here.

<iframe src="https://newsmarkets.org/embed/story/indian-drugmaker-taps-private-credit-for-japanese-acquisition-35209" width="100%" height="420" style="border:0;max-width:640px" loading="lazy" title="Indian Drugmaker Taps Private Credit for Japanese Acquisition · NewsMarkets"></iframe>

Sources

Every article we clustered into this story. Headlines link to the publisher.

Indian Drugmaker Taps Private Credit for Japanese Acquisition Bloomberg Markets · 3d ago

In this story

Gujarat Themis Biosyn Ltd.
MicroBiopharm Japan Co.